NervGen Pharma Corp. (NGENF)
USD 2.53
(12.44%)
USD 2.53
(12.44%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -22.38 Million CAD | -8.01% |
| 2022 | -20.72 Million CAD | -62.83% |
| 2021 | -12.72 Million CAD | -13.77% |
| 2020 | -11.18 Million CAD | -14.55% |
| 2019 | -9.76 Million CAD | -618.86% |
| 2018 | -1.35 Million CAD | -11399.9% |
| 2017 | -11.81 Thousand CAD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | -2.3 Million CAD | 73.28% |
| 2024 Q2 | -7.82 Million CAD | -240.26% |
| 2023 Q2 | -4.76 Million CAD | -1.13% |
| 2023 Q1 | -4.7 Million CAD | 20.73% |
| 2023 FY | -22.38 Million CAD | -8.01% |
| 2023 Q3 | -4.3 Million CAD | 9.65% |
| 2023 Q4 | -8.6 Million CAD | -100.08% |
| 2022 FY | -20.72 Million CAD | -62.83% |
| 2022 Q4 | -5.94 Million CAD | -69.92% |
| 2022 Q3 | -3.49 Million CAD | 44.67% |
| 2022 Q2 | -6.31 Million CAD | -27.19% |
| 2022 Q1 | -4.96 Million CAD | -19.79% |
| 2021 Q2 | -2.73 Million CAD | -21.6% |
| 2021 Q1 | -2.24 Million CAD | 50.84% |
| 2021 Q3 | -3.59 Million CAD | -31.7% |
| 2021 Q4 | -4.14 Million CAD | -15.21% |
| 2021 FY | -12.72 Million CAD | -13.77% |
| 2020 FY | -11.18 Million CAD | -14.55% |
| 2020 Q1 | -1.85 Million CAD | 35.61% |
| 2020 Q4 | -4.57 Million CAD | -114.29% |
| 2020 Q3 | -2.13 Million CAD | 18.63% |
| 2020 Q2 | -2.62 Million CAD | -41.01% |
| 2019 Q3 | -2.33 Million CAD | -52.87% |
| 2019 Q4 | -2.88 Million CAD | -23.87% |
| 2019 FY | -9.76 Million CAD | -618.86% |
| 2019 Q2 | -1.52 Million CAD | 49.53% |
| 2019 Q1 | -3.02 Million CAD | -293.45% |
| 2018 Q1 | -10.62 Thousand CAD | -42.51% |
| 2018 Q2 | -64.35 Thousand CAD | -505.7% |
| 2018 FY | -1.35 Million CAD | -11399.9% |
| 2018 Q3 | -515.54 Thousand CAD | -701.15% |
| 2018 Q4 | -767.96 Thousand CAD | -48.96% |
| 2017 FY | -11.81 Thousand CAD | 0.0% |
| 2017 Q3 | -3367.00 CAD | -643.27% |
| 2017 Q4 | -7455.00 CAD | -121.41% |
| 2017 Q2 | -453.00 CAD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Bioxytran, Inc. | -4.28 Million USD | -422.946% |
| Eiger BioPharmaceuticals, Inc. | -74.96 Million USD | 70.142% |
| Institute of Biomedical Research Corp. | -273.4 Thousand USD | -8086.524% |
| SQZ Biotechnologies Company | -79.46 Million USD | 71.834% |
| Intellipharmaceutics International Inc. | -2.89 Million USD | -673.827% |
| Evofem Biosciences, Inc. | 52.97 Million USD | 142.247% |
| Santhera Pharmaceuticals Holding AG | 65.13 Million USD | 134.364% |
| Propanc Biopharma, Inc. | -1.82 Million USD | -1129.43% |
| Marizyme, Inc. | -65.34 Million USD | 65.749% |
| Genus plc | 7.9 Million USD | 383.318% |
| Pharming Group N.V. | -10.54 Million USD | -112.193% |
| Therapeutic Solutions International, Inc. | -2.16 Million USD | -931.523% |
| CNBX Pharmaceuticals Inc. | -3.71 Million USD | -503.254% |
| Nymox Pharmaceutical Corporation | -8.84 Million USD | -153.077% |
| ContraFect Corporation | -65.15 Million USD | 65.647% |
| RegeneRx Biopharmaceuticals, Inc. | -1.72 Million USD | -1195.67% |
| IMV Inc. | -36.48 Million USD | 38.655% |
| AXIM Biotechnologies, Inc. | -8.05 Million USD | -177.705% |
| ONE Bio Corp. | 8.67 Million USD | 357.959% |
| RVL Pharmaceuticals plc | -51.69 Million USD | 56.701% |
| Mesoblast Limited | -87.95 Million USD | 74.553% |
| MultiCell Technologies, Inc. | -380.07 USD | -5888846.773% |
| Arno Therapeutics, Inc. | - USD | Infinity% |
| Emmaus Life Sciences, Inc. | -3.73 Million USD | -499.575% |
| Genscript Biotech Corporation | -95.47 Million USD | 76.558% |
| Neon Bloom, Inc. | -632.4 Thousand USD | -3439.195% |
| Mosaic ImmunoEngineering Inc. | -2.38 Million USD | -840.082% |
| Nanobac Pharmaceuticals, Incorporated | -6.57 Million USD | -240.355% |
| Biomind Labs Inc. | -1.21 Million USD | -1743.183% |
| Provectus Biopharmaceuticals, Inc. | -3.1 Million USD | -621.592% |
| Oncotelic Therapeutics, Inc. | -7.9 Million USD | -183.207% |
| Skye Bioscience, Inc. | -37.64 Million USD | 40.544% |
| GlobeStar Therapeutics Corporation | -1.94 Million USD | -1048.243% |
| VioQuest Pharmaceuticals, Inc. | -10.89 Million USD | -105.496% |
| THC Farmaceuticals, Inc. | -14.97 Thousand USD | -149353.259% |
| PsyBio Therapeutics Corp. | -4.88 Million USD | -358.081% |
| Arch Therapeutics, Inc. | -6.98 Million USD | -220.531% |
| Sienna Biopharmaceuticals, Inc. | - USD | Infinity% |
| Acro Biomedical Co., Ltd. | -15.87 Million USD | -41.021% |
| Accustem Sciences Inc. | -3.74 Million USD | -497.427% |
| EV Biologics, Inc. | -1.26 Million USD | -1666.358% |
| Q BioMed Inc. | -2.05 Million USD | -990.697% |
| GB Sciences, Inc. | -1.36 Million USD | -1543.717% |
| Alpha Cognition Inc. | -13.77 Million USD | -62.512% |
| CSL Limited | 2.64 Billion USD | 100.847% |
| Agentix Corp. | -1.37 Million USD | -1528.725% |
| American Oriental Bioengineering, Inc. | -59.72 Million USD | 62.525% |
| Enzolytics Inc. | -2.17 Million USD | -928.197% |
| TetraLogic Pharmaceuticals Corporation | - USD | Infinity% |
| Resverlogix Corp. | -3.61 Million USD | -520.003% |
| Nuo Therapeutics, Inc. | -3.17 Million USD | -605.741% |
| MetaStat, Inc. | - USD | Infinity% |
| Curative Biotechnology, Inc. | -5.81 Million USD | -284.754% |
| argenx SE | -295.05 Million USD | 92.414% |
| Northwest Biotherapeutics, Inc. | -62.59 Million USD | 64.245% |
| HST Global, Inc. | -146.21 Thousand USD | -15208.201% |
| Enzon Pharmaceuticals, Inc. | 98 Thousand USD | 22938.898% |
| Wesana Health Holdings Inc. | -1.75 Million USD | -1175.501% |
| Halberd Corporation | -79.67 Thousand USD | -27991.42% |
| Endonovo Therapeutics, Inc. | 6.92 Million USD | 423.226% |
| Inhibitor Therapeutics, Inc. | -3.02 Million USD | -639.627% |
| Zenith Capital Corp. | -10.59 Million USD | -111.232% |
| RespireRx Pharmaceuticals Inc. | -3.97 Million USD | -463.357% |
| GeneThera, Inc. | - USD | Infinity% |
| Sigyn Therapeutics, Inc. | -4.14 Million USD | -439.857% |
| AVAX Technologies, Inc. | -6.41 Million USD | -248.976% |
| WPD Pharmaceuticals Inc. | -60.44 Thousand USD | -36931.592% |
| Cotinga Pharmaceuticals Inc. | -2 Million USD | -1016.251% |
| Ember Therapeutics, Inc. | -23.24 Thousand USD | -96200.318% |
| Anthera Pharmaceuticals, Inc. | - USD | Infinity% |
| Adynxx, Inc. | - USD | Infinity% |
| NovAccess Global Inc. | -4.76 Million USD | -369.307% |
| Helix BioMedix, Inc. | -1.05 Million USD | -2019.405% |
| Capstone Therapeutics Corp. | -3.81 Million USD | -486.073% |
| Kadimastem Ltd | -3.3 Million USD | -576.729% |
| VitaSpring Biomedical Co. Ltd. | - USD | Infinity% |
| BioStem Technologies, Inc. | -8.48 Million USD | -163.847% |
| Oncology Pharma Inc. | - USD | Infinity% |
| Reve Technologies, Inc. | -441.36 Thousand USD | -4971.068% |
| Burzynski Research Institute, Inc. | -1.33 Million USD | -1576.022% |
| LadRx Corporation | 400.44 Thousand USD | 5689.34% |
| Cell Source, Inc. | -5.32 Million USD | -320.621% |
| ProtoKinetix, Incorporated | -415.47 Thousand USD | -5287.064% |
| Regen BioPharma, Inc. | 1.02 Million USD | 2286.805% |
| Regen BioPharma, Inc. | 1.02 Million USD | 2286.805% |
| Affymax, Inc. | -14.42 Million USD | -55.173% |
| Mobile Lads Corp. | -2.26 Million USD | -888.919% |
| Itoco Inc. | -1.86 Million USD | -1097.548% |
| Rasna Therapeutics, Inc. | -4.44 Million USD | -403.814% |
| Pathfinder Cell Therapy, Inc. | -1.66 Million USD | -1241.05% |
| International Stem Cell Corporation | -131 Thousand USD | -16985.588% |
| CytoDyn Inc. | -49.84 Million USD | 55.093% |
| Claritas Pharmaceuticals, Inc. | - USD | Infinity% |
| NDT Pharmaceuticals Inc. | -79.03 Thousand USD | -28219.968% |
| NanoSphere Health Sciences Inc. | -228.12 Thousand USD | -9711.254% |
| Qrons Inc. | -789.34 Thousand USD | -2735.524% |
| Alseres Pharmaceuticals, Inc. | -941.52 Thousand USD | -2277.21% |
| SYBLEU INC | -180.3 Thousand USD | -12313.546% |
| Advanced Proteome Therapeutics Corporation | - USD | Infinity% |
| Nascent Biotech, Inc. | -2.08 Million USD | -972.104% |
| Rebus Holdings, Inc. | -1.02 Million USD | -2094.325% |
| GlobeImmune, Inc. | - USD | Infinity% |
| ImmunoCellular Therapeutics, Ltd. | -1.61 Million USD | -1287.834% |
| Predictive Technology Group, Inc. | - USD | Infinity% |
| ProText Mobility, Inc. | -54.27 Thousand USD | -41140.64% |
| Cardax, Inc. | - USD | Infinity% |
| VG Life Sciences Inc. | -2.53 Million USD | -784.582% |
| Kaleido Biosciences, Inc. | - USD | Infinity% |
| Advaxis, Inc. | -48.07 Million USD | 53.44% |
| Adhera Therapeutics, Inc. | -2.11 Million USD | -958.757% |
| RenovaCare, Inc. | - USD | Infinity% |
| Regnum Corp. | -780.88 Thousand USD | -2766.243% |
| Innovation Pharmaceuticals Inc. | -3.16 Million USD | -606.506% |
| Neutra Corp. | -233.46 Thousand USD | -9486.927% |
| Windtree Therapeutics, Inc. | -20.29 Million USD | -10.306% |
| PureTech Health plc | -65.69 Million USD | 65.931% |
| Coeptis Therapeutics, Inc. | -21.26 Million USD | -5.246% |
| IXICO plc | -1.17 Million USD | -1800.01% |
| IntelGenx Technologies Corp. | -9.92 Million USD | -125.467% |
| Gelesis Holdings, Inc. | -57.12 Million USD | 60.821% |
| CSL Limited | 2.64 Billion USD | 100.847% |
| Cellectis S.A. | -103.17 Million USD | 78.306% |